Đang chuẩn bị liên kết để tải về tài liệu:
Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance

The purpose of this study was to evaluate serum HE4 as a biomarker to detect recurrent disease during follow-up of patients with endometrial adenocarcinoma (EAC). Methods: We performed a retrospective analysis of 98 EAC patients treated at Innsbruck Medical University, between 1999 and 2009. Twenty-six patients developed recurrent disease. Median follow-up was 5 years. |